Home
BIAF
BIAF News

Latest bioAffinity Technologies Inc. (BIAF) News on November 22, 2024

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

Business Wire

8 days ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q3 2024

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

Business Wire

18 days ago

bioAffinity Technologies Appoints New Chief Science Officer to Spearhead Product Development

MT Newswires

23 days ago

bioAffinity Technologies Secures Japanese Patent for Lung Cancer Diagnostic Method

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

Business Wire

23 days ago

bioAffinity Technologies Announces Award of Japanese Patent for CyPath® Lung

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

PR Newswire

a month ago

WallachBeth Capital Announces Closing of bioAffinity Technologies $2.6 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

Business Wire

a month ago

bioAffinity Technologies Announces Closing of $2.6 Million Registered Direct Offering & Concurrent Private Placement

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement

PR Newswire

a month ago

WallachBeth Capital Announces Pricing of bioAffinity Technologies $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement

Business Wire

a month ago

bioAffinity Technologies Announces Pricing of $2.66 Million Registered Direct Offering & Concurrent Private Placement

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines

Business Wire

a month ago

bioAffinity’s CyPath® Lung Cancer Test Supported by Newly Published Flow Cytometry Guidelines

MT Newswires

a month ago

BioAffinity Technologies Appoints J. Michael Edwards as CFO

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer

Business Wire

a month ago

bioAffinity Technologies Names J. Michael Edwards as Chief Financial Officer

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

Business Wire

a month ago

bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis

Business Wire

2 months ago

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO

Business Wire

3 months ago

bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales

Business Wire

3 months ago

bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales

MT Newswires

4 months ago

BioAffinity Raises Nearly $1.8 Million From Offerings

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

Business Wire

4 months ago

bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

PR Newswire

4 months ago

WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

Business Wire

4 months ago

bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

4 months ago

Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

Business Wire

4 months ago

bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

ACCESSWIRE

5 months ago

BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

Business Wire

5 months ago

bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

Business Wire

6 months ago

bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes

bioAffinity Technologies News Update

Business Wire

7 months ago

bioAffinity Technologies News Update

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

Business Wire

7 months ago

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

Business Wire

7 months ago

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

8 months ago

bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

PR Newswire

8 months ago

Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Business Wire

8 months ago

bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

PR Newswire

9 months ago

WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Business Wire

9 months ago

bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Business Wire

9 months ago

bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

Simply Wall St.

9 months ago

Here's Why We're A Bit Worried About bioAffinity Technologies' (NASDAQ:BIAF) Cash Burn Situation

bioAffinity Technologies News Update

Business Wire

9 months ago

bioAffinity Technologies News Update

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

Business Wire

10 months ago

Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical Practice

bioAffinity Technologies In The News

Business Wire

10 months ago

bioAffinity Technologies In The News

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

ACCESSWIRE

10 months ago

BM Technologies (BMTX) Champions Campus Excellence and Announces 2023 ACE Award and Partnership Winners

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

GlobeNewswire

10 months ago

Genius Group and FatBrain AI Agree to Merge into Growth Platform to Accelerate the Exponential Economy of Tomorrow

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Business Wire

10 months ago

bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

Zacks

10 months ago

Orion (OESX) Preliminary Q3 Results Depict Strong Demand

MAIA Soars 20% on Interim Results From Lung Cancer Study

Zacks

10 months ago

MAIA Soars 20% on Interim Results From Lung Cancer Study

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Business Wire

10 months ago

MAIA Biotechnology Provides Positive Phase 2 Clinical Updates for Lead Anticancer Agent and Outlines Targeted Milestones for 2024

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10

Simply Wall St.

10 months ago

Glen Burnie Bancorp's (NASDAQ:GLBZ) Dividend Will Be $0.10

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

GlobeNewswire

10 months ago

VYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of Vitiligo

The Container Store lowers Q3 sales guidance

Retail Dive

10 months ago

The Container Store lowers Q3 sales guidance

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

ACCESSWIRE

a year ago

bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

GlobeNewswire

a year ago

VYNE Therapeutics Appoints Christine Borowski, Ph.D., to its Board of Directors

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

InvestorPlace

a year ago

3 Penny Stocks to Make You the Millionaire Next Door: 2024 Edition

Pacira Appoints Frank D. Lee as Chief Executive Officer

GlobeNewswire

a year ago

Pacira Appoints Frank D. Lee as Chief Executive Officer

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results

GuruFocus.com

a year ago

Innovative Solutions and Support Inc (ISSC) Reports Strong Q4 and Full Year Fiscal 2023 Results

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom

GlobeNewswire

a year ago

PodcastOne (NASDAQ: PODC) Acquires Exclusive Rights to Hit Podcast Was I In A Cult? From Hosts Liz Iacuzzi and Tyler Measom

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

GlobeNewswire

a year ago

Cara Therapeutics Announces Outcome from Dose-Finding Part A of KIND 1 Study Evaluating Oral Difelikefalin for Moderate-to-Severe Pruritus in Patients with Atopic Dermatitis

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Simply Wall St.

a year ago

Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

GlobeNewswire

a year ago

Kustom Entertainment Inc. and Clover Leaf Capital Corp. Amend the Lock-Up Agreement in their Proposed Business Combination

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

ACCESSWIRE

a year ago

Moolec Science to Host First Quarter Fiscal Year 2024 Business Update Conference Call

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

GlobeNewswire

a year ago

Lead Real Estate Co., Ltd Announces Sale of 17-unit Luxury Condominium in Tokyo

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Business Wire

a year ago

bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

GlobeNewswire

a year ago

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

GlobeNewswire

a year ago

GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

Zacks

a year ago

Down -38.07% in 4 Weeks, Here's Why You Should You Buy the Dip in Trevi Therapeutics, Inc. (TRVI)

ACCESSWIRE

a year ago

Vivakor Reports 39% Revenue Growth to $16.3 Million Revenue for Third Quarter 2023

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

Business Wire

a year ago

CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Business Wire

a year ago

bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post

Old Point Financial Corporation Declares Quarterly Dividend

PR Newswire

a year ago

Old Point Financial Corporation Declares Quarterly Dividend

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

GlobeNewswire

a year ago

Lead Real Estate Co., Ltd Reports Fiscal 2023 Year-end Financial Results

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

GlobeNewswire

a year ago

CPI Aerostructures Receives $4.4M Orders from Embraer for Engine Inlet Assemblies

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

PR Newswire

a year ago

Leap Therapeutics to Participate at Piper Sandler 35th Annual Healthcare Conference

ACCESSWIRE

a year ago

Vivakor Announces Results of Special Meeting of Shareholders with All Proposals Approved with Greater than 90% Voted For Each Proposal

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago

Simply Wall St.

a year ago

Farmer Bros (NASDAQ:FARM) investors are sitting on a loss of 89% if they invested five years ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

Business Wire

a year ago

bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

a year ago

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks

a year ago

Trevi Therapeutics, Inc. (TRVI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

Simply Wall St.

a year ago

Individual investors account for 54% of Genenta Science S.p.A.'s (NASDAQ:GNTA) ownership, while insiders account for 30%

Hour Loop Reports Third Quarter 2023 Results

GlobeNewswire

a year ago

Hour Loop Reports Third Quarter 2023 Results

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Simply Wall St.

a year ago

Heritage Global Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Thomson Reuters StreetEvents

a year ago

Q3 2023 Achieve Life Sciences Inc Earnings Call

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

Insider Monkey

a year ago

Smart Sand, Inc. (NASDAQ:SND) Q3 2023 Earnings Call Transcript

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

GlobeNewswire

a year ago

Sensus Healthcare to Host Third Quarter 2023 Financial Results and Business Update Conference Call on Thursday, November 9, 2023

ACCESSWIRE

a year ago

Vivakor Issues Shareholder Update

Share on Social Networks: